Supply Chain Performance of Anti-Retro Viral Therapy Drugs Management Practice in Selected Public Health Hospitals Under Addis-Ababa City Administration Government Health Bureau
No Thumbnail Available
Date
2024-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa University
Abstract
It was found that proper management of anti-retroviral medications and related products is essential to improving efficient product flow and avoiding frequent stockouts of essential items, which could reduce the program's impact on the general public. It was noted that HIV treatment involves lifelong therapy and that few or no substitutes may be made in the event of stockouts, treatment failure, or missed opportunities for diagnosis as a result of stockouts, presenting a particularly difficult problem. Ineffective logistics and supply chain management for these commodities were found to result in a large loss of resources.
The general objective of this study was to assess the supply chain of Anti-retroviral drugs for HIV/AIDS at public hospitals under the Addis Ababa City Government Health Bureau. Both qualitative and quantitative data analysis were used using a semi-structured questionnaire and an observation checklist, respectively. Data gathering for the project was completed within two months.
The data was used to determine the key performance indicators, and the system's current state was evaluated by comparing the data to the inventory management system that was chosen. Physical inventory was found to be a crucial step in figuring out how much ARV medication needs to be ordered and how much is actually in stock.
It was found that six hospitals had access to more than 80% of the ART medications: TDF+3TC+DTG (300+300+50mg) tab, TDF+3TC (300+300mg) tab, EFV 600mg, EFV 600mg, 3TC 150mg tab, AZT + 3TC (300mg + 150mg) tab, and ABC 300 tab were 100% available ART medications, while DTG 50mg tab and DRV 600mg tab were 2 (33.3%) available ART medications, but 4 (66.7%) were not available in public hospitals under AACAHB. AZT + 3TC (300 + 150 mg) tab, ATZ/r 300 mg/100 mg tab, Lopinavir 200mg/Ritonavir 50mg tablet, and ABC/3TC 120 mg/60 mg (pedi) tablet were 5 (83.7%) available ART medications, but 1 (16.7%) were not available in public hospitals under AACAHB. RTV 100mg tab and Lopinavir 100mg/Ritonavir 25mg Tablet (pedi) were 1 (16.7%) available ART medications, but 5 (83.7%) were not available. Lamivudine 30mg/Zidovudine 60mg pedi Tablets and Cotrimoxazole 240 mg/5 ml suspension for pediatric OI drugs were not available due to stock out and expiration
Key words: available ART medications, Supply Chain Performance, Logistics management.